Cargando…

Expression of a Truncated, Kinase-Defective TGF-β Type II Receptor in Mouse Skeletal Tissue Promotes Terminal Chondrocyte Differentiation and Osteoarthritis

Members of the TGF-β superfamily are important regulators of skeletal development. TGF-βs signal through heteromeric type I and type II receptor serine/threonine kinases. When over-expressed, a cytoplasmically truncated type II receptor can compete with the endogenous receptors for complex formation...

Descripción completa

Detalles Bibliográficos
Autores principales: Serra, Rosa, Johnson, Mahlon, Filvaroff, Ellen H., LaBorde, James, Sheehan, Daniel M., Derynck, Rik, Moses, Harold L.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1997
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2139797/
https://www.ncbi.nlm.nih.gov/pubmed/9334355
_version_ 1782143879988903936
author Serra, Rosa
Johnson, Mahlon
Filvaroff, Ellen H.
LaBorde, James
Sheehan, Daniel M.
Derynck, Rik
Moses, Harold L.
author_facet Serra, Rosa
Johnson, Mahlon
Filvaroff, Ellen H.
LaBorde, James
Sheehan, Daniel M.
Derynck, Rik
Moses, Harold L.
author_sort Serra, Rosa
collection PubMed
description Members of the TGF-β superfamily are important regulators of skeletal development. TGF-βs signal through heteromeric type I and type II receptor serine/threonine kinases. When over-expressed, a cytoplasmically truncated type II receptor can compete with the endogenous receptors for complex formation, thereby acting as a dominant-negative mutant (DNIIR). To determine the role of TGF-βs in the development and maintenance of the skeleton, we have generated transgenic mice (MT-DNIIR-4 and -27) that express the DNIIR in skeletal tissue. DNIIR mRNA expression was localized to the periosteum/perichondrium, syno-vium, and articular cartilage. Lower levels of DNIIR mRNA were detected in growth plate cartilage. Transgenic mice frequently showed bifurcation of the xiphoid process and sternum. They also developed progressive skeletal degeneration, resulting by 4 to 8 mo of age in kyphoscoliosis and stiff and torqued joints. The histology of affected joints strongly resembled human osteo-arthritis. The articular surface was replaced by bone or hypertrophic cartilage as judged by the expression of type X collagen, a marker of hypertrophic cartilage normally absent from articular cartilage. The synovium was hyperplastic, and cartilaginous metaplasia was observed in the joint space. We then tested the hypothesis that TGF-β is required for normal differentiation of cartilage in vivo. By 4 and 8 wk of age, the level of type X collagen was increased in growth plate cartilage of transgenic mice relative to wild-type controls. Less proteoglycan staining was detected in the growth plate and articular cartilage matrix of transgenic mice. Mice that express DNIIR in skeletal tissue also demonstrated increased Indian hedgehog (IHH) expression. IHH is a secreted protein that is expressed in chondrocytes that are committed to becoming hypertrophic. It is thought to be involved in a feedback loop that signals through the periosteum/ perichondrium to inhibit cartilage differentiation. The data suggest that TGF-β may be critical for multifaceted maintenance of synovial joints. Loss of responsiveness to TGF-β promotes chondrocyte terminal differentiation and results in development of degenerative joint disease resembling osteoarthritis in humans.
format Text
id pubmed-2139797
institution National Center for Biotechnology Information
language English
publishDate 1997
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21397972008-05-01 Expression of a Truncated, Kinase-Defective TGF-β Type II Receptor in Mouse Skeletal Tissue Promotes Terminal Chondrocyte Differentiation and Osteoarthritis Serra, Rosa Johnson, Mahlon Filvaroff, Ellen H. LaBorde, James Sheehan, Daniel M. Derynck, Rik Moses, Harold L. J Cell Biol Article Members of the TGF-β superfamily are important regulators of skeletal development. TGF-βs signal through heteromeric type I and type II receptor serine/threonine kinases. When over-expressed, a cytoplasmically truncated type II receptor can compete with the endogenous receptors for complex formation, thereby acting as a dominant-negative mutant (DNIIR). To determine the role of TGF-βs in the development and maintenance of the skeleton, we have generated transgenic mice (MT-DNIIR-4 and -27) that express the DNIIR in skeletal tissue. DNIIR mRNA expression was localized to the periosteum/perichondrium, syno-vium, and articular cartilage. Lower levels of DNIIR mRNA were detected in growth plate cartilage. Transgenic mice frequently showed bifurcation of the xiphoid process and sternum. They also developed progressive skeletal degeneration, resulting by 4 to 8 mo of age in kyphoscoliosis and stiff and torqued joints. The histology of affected joints strongly resembled human osteo-arthritis. The articular surface was replaced by bone or hypertrophic cartilage as judged by the expression of type X collagen, a marker of hypertrophic cartilage normally absent from articular cartilage. The synovium was hyperplastic, and cartilaginous metaplasia was observed in the joint space. We then tested the hypothesis that TGF-β is required for normal differentiation of cartilage in vivo. By 4 and 8 wk of age, the level of type X collagen was increased in growth plate cartilage of transgenic mice relative to wild-type controls. Less proteoglycan staining was detected in the growth plate and articular cartilage matrix of transgenic mice. Mice that express DNIIR in skeletal tissue also demonstrated increased Indian hedgehog (IHH) expression. IHH is a secreted protein that is expressed in chondrocytes that are committed to becoming hypertrophic. It is thought to be involved in a feedback loop that signals through the periosteum/ perichondrium to inhibit cartilage differentiation. The data suggest that TGF-β may be critical for multifaceted maintenance of synovial joints. Loss of responsiveness to TGF-β promotes chondrocyte terminal differentiation and results in development of degenerative joint disease resembling osteoarthritis in humans. The Rockefeller University Press 1997-10-20 /pmc/articles/PMC2139797/ /pubmed/9334355 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Article
Serra, Rosa
Johnson, Mahlon
Filvaroff, Ellen H.
LaBorde, James
Sheehan, Daniel M.
Derynck, Rik
Moses, Harold L.
Expression of a Truncated, Kinase-Defective TGF-β Type II Receptor in Mouse Skeletal Tissue Promotes Terminal Chondrocyte Differentiation and Osteoarthritis
title Expression of a Truncated, Kinase-Defective TGF-β Type II Receptor in Mouse Skeletal Tissue Promotes Terminal Chondrocyte Differentiation and Osteoarthritis
title_full Expression of a Truncated, Kinase-Defective TGF-β Type II Receptor in Mouse Skeletal Tissue Promotes Terminal Chondrocyte Differentiation and Osteoarthritis
title_fullStr Expression of a Truncated, Kinase-Defective TGF-β Type II Receptor in Mouse Skeletal Tissue Promotes Terminal Chondrocyte Differentiation and Osteoarthritis
title_full_unstemmed Expression of a Truncated, Kinase-Defective TGF-β Type II Receptor in Mouse Skeletal Tissue Promotes Terminal Chondrocyte Differentiation and Osteoarthritis
title_short Expression of a Truncated, Kinase-Defective TGF-β Type II Receptor in Mouse Skeletal Tissue Promotes Terminal Chondrocyte Differentiation and Osteoarthritis
title_sort expression of a truncated, kinase-defective tgf-β type ii receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2139797/
https://www.ncbi.nlm.nih.gov/pubmed/9334355
work_keys_str_mv AT serrarosa expressionofatruncatedkinasedefectivetgfbtypeiireceptorinmouseskeletaltissuepromotesterminalchondrocytedifferentiationandosteoarthritis
AT johnsonmahlon expressionofatruncatedkinasedefectivetgfbtypeiireceptorinmouseskeletaltissuepromotesterminalchondrocytedifferentiationandosteoarthritis
AT filvaroffellenh expressionofatruncatedkinasedefectivetgfbtypeiireceptorinmouseskeletaltissuepromotesterminalchondrocytedifferentiationandosteoarthritis
AT labordejames expressionofatruncatedkinasedefectivetgfbtypeiireceptorinmouseskeletaltissuepromotesterminalchondrocytedifferentiationandosteoarthritis
AT sheehandanielm expressionofatruncatedkinasedefectivetgfbtypeiireceptorinmouseskeletaltissuepromotesterminalchondrocytedifferentiationandosteoarthritis
AT derynckrik expressionofatruncatedkinasedefectivetgfbtypeiireceptorinmouseskeletaltissuepromotesterminalchondrocytedifferentiationandosteoarthritis
AT mosesharoldl expressionofatruncatedkinasedefectivetgfbtypeiireceptorinmouseskeletaltissuepromotesterminalchondrocytedifferentiationandosteoarthritis